Atai Beckley, Inc. (ATAI)
4.00
-0.17
(-4.08%)
USD |
NASDAQ |
May 07, 14:16
Atai Beckley Cash from Investing (Quarterly) : -40.59M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Definium Therapeutics, Inc. | 37.53M |
| Compass Pathways Plc | 0.00 |
| GH Research Plc | 8.566M |
| Eli Lilly & Co. | -3.916B |
| Nektar Therapeutics | 0.372M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -48.15M |
| Cash from Financing (Quarterly) | 144.96M |
| Free Cash Flow | -117.10M |
| Free Cash Flow Per Share (Quarterly) | -0.1862 |
| Free Cash Flow to Equity (Quarterly) | -57.65M |
| Free Cash Flow to Firm (Quarterly) | -58.53M |
| Free Cash Flow Yield | -12.94% |